Notice of Award of a Single-Source Cooperative Agreement To Fund the Sierra Leone Ministry of Health and Sanitation, 6550-6551 [2022-02407]
Download as PDF
<![CDATA[
6550
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices
health policies under the control of
Ministry of Health through the GHS
Governing Council. GHS has the
Mandate to provide and manage
comprehensive and accessible health
services with special emphasis on
primary health care at regional, district,
and sub-district levels.
Summary of the Award
Recipient: Ghana Health Service.
Purpose of the Award: The purpose of
this award is to build laboratory and SI
capacity to improve the provision of
HIV testing, treatment, and retention in
line with HIV epidemic control and 95–
95–95 targets. This award strives to
build and strengthen laboratories with
the appropriate diagnostic technologies,
trained and skilled staff, and systems
that can provide efficient services. It
also strengthens SI systems, data quality
assurance, and the capacity of staff
responsible for managing facility-based,
survey, and surveillance data operating
at national and subnational levels.
Amount of Award: The approximate
year 1 funding amount will be $800,000
in Federal Fiscal Year (FFY) 2022 funds,
subject to the availability of funds.
Funding amounts for years 2–5 will be
set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30,
2022 through September 29, 2027.
Dated: February 1, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–02410 Filed 2–3–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund the
National AIDS Control Program,
Programme National de Lutte contre le
VIH/SIDA (PNLS), Democratic Republic
of Congo
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
lotter on DSK11XQN23PROD with NOTICES1
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $500,000 for
SUMMARY:
VerDate Sep<11>2014
18:50 Feb 03, 2022
Jkt 256001
Year 1 of funding to the Programme
National de Lutte contre le VIH/SIDA
(PNLS). The award will strengthen
Strategic Information (SI) activities,
laboratory quality assurance services,
and surveillance of new infections in
Democratic Republic of Congo (DRC).
This support will enhance the
antiretroviral therapy (ART) cohort
monitoring and delivery of HIV/AIDS
services for the epidemic control in
DRC. Funding amounts for years 2–5
will be set at continuation.
DATES: The period for this award will be
September 30, 2022 through September
29, 2027.
FOR FURTHER INFORMATION CONTACT:
Kaee Ross, Center for Global Health,
Centers for Disease Control and
Prevention, U.S. Embassy DRC, 498 Ave
Col Lukusa, Kinshasa, Gombe, DRC,
Telephone: 800–232–6348, email: knr6@
cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will improve data
collection and analysis to produce a
factual basis for evaluation and
improvement of the HIV prevention,
care, and treatment program in the DRC.
The project will build capacity in DRC
to have available, reliable data
transmitted promptly for decisionmaking. Furthermore, the project will
sustain quality assurance for rapid tests
to ensure accuracy of results, and the
monitoring of rapid tests used in the
field.
The PNLS is a specialized program
run by the Ministry of Health (MOH) in
the DRC. Created on August 5, 2015 by
Ministerial Decision No. 449/MSLS/
CAB, the PNLS has been authorized and
tasked to lead and coordinate the fight
against the HIV/AIDS epidemic to
achieve epidemic control. The PNLS is
the governmental authority with the
normative and regulatory role in the
implementation of STI and HIV/AIDS
control activities in the Health Zones
(HZ). The PNLS has the authority to
organize, review, and validate all data
relative to HIV–AIDS in country. In
addition, PNLS has the mission to
control the quality of rapid test results
provided by health care workers at
facilities and to monitor how rapid tests
are working in the field. Accordingly,
PNLS has the sole authority and is
uniquely qualified to perform the
anticipated activities for this award.
Summary of the Award
Recipient: the Programme National de
Lutte contre le VIH/SIDA (PNLS).
Purpose of the Award: The purpose of
this award is to strengthen SI activities,
laboratory quality assurance services,
and surveillance of new infections in
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
DRC. Support from this award will
enhance ART cohort monitoring and
delivery of HIV/AIDS services for
control of the epidemic in DRC.
Amount of Award: The approximate
year 1 funding amount will be $500,000
in Federal Fiscal Year (FFY) 2022 funds,
subject to the availability of funds.
Funding amounts for years 2–5 will be
set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30,
2022 through September 29, 2027.
Dated: February 1,2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–02411 Filed 2–3–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund the
Sierra Leone Ministry of Health and
Sanitation
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $450,000 for
Year 1 of funding to the Sierra Leone
(SL) Ministry of Health and Sanitation.
The award will build laboratory and
Strategic Information (SI) capacity to
improve the provision of HIV testing,
treatment, and retention in line with
HIV epidemic control and 95–95–
95(95% of HIV-positive individuals
knowing their status, 95% of those
receiving ART [Antiretroviral therapy],
and 95% of those achieving viral
suppression) targets. Funding amounts
for years 2–5 will be set at continuation.
DATES: The period for this award will be
September 30, 2022 through September
29, 2027.
FOR FURTHER INFORMATION CONTACT:
Trong Ao, Center for Global Health,
Centers for Disease Control and
Prevention, CDC Ghana Office, U.S.
Embassy, 24 Fourth Circular Road
Cantonments, Accra, Ghana, Telephone:
800–232–6348, Email: tfa8@cdc.gov.
SUMMARY:
E:\FR\FM\04FEN1.SGM
04FEN1
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices
The
single-source award will support the
National AIDS Control Program of Sierra
Leone (SL) in the Ministry of Health and
Sanitation to implement HIV strategic
information and laboratory
strengthening activities in SL. This
award will build and strengthen
laboratories that are equipped with the
appropriate diagnostic technologies,
trained and skilled staff, and systems
that have the capability to provide
efficient services. It will also strengthen
SI systems, data quality assurance and
capacity of staff responsible for
managing facility-based survey and
surveillance data operating at national
and subnational levels. As the mandated
institution to provide HIV treatment
clinical services and guidelines in SL,
the Sierra Leone Ministry of Health and
Sanitation is in a unique position to
conduct this work. The National HIV/
AIDS control program is one of the
specialized programs within the
Ministry of Health.
SUPPLEMENTARY INFORMATION:
Summary of the Award
Recipient: Sierra Leone Ministry of
Health and Sanitation.
Purpose of the Award: The purpose of
this award is to build laboratory and SI
capacity to improve the provision of
HIV testing, treatment, and retention in
line with HIV epidemic control and 95–
95–95 targets. The award will build and
strengthen laboratories that are
equipped with the appropriate
diagnostic technologies, trained and
skilled staff, and systems that have the
capability to provide efficient services.
Amount of Award: The approximate
year 1 funding amount will be $450,000
in Federal Fiscal Year (FFY) 2022 funds,
subject to the availability of funds.
Funding amounts for years 2–5 will be
set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30,
2022 through September 29, 2027.
lotter on DSK11XQN23PROD with NOTICES1
Dated: February 1, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–02407 Filed 2–3–22; 8:45 am]
18:50 Feb 03, 2022
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Delegation of Authority
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–CE–22–013: Rigorous Evaluation
of Community-Centered Approaches for
the Prevention of Community Violence.
Date: June 28–29, 2022.
Time: 8:30 a.m.–5:30 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Mikel Walters, Ph.D., Scientific Review
Official, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop F–63,
Atlanta, Georgia 30341, Telephone (404)
639–0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 4163–18–P
VerDate Sep<11>2014
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Jkt 256001
6551
Notice is hereby given that the
Director, Centers for Disease Control
and Prevention (CDC), has delegated to
the Chief Operating Officer, CDC,
without the authority to redelegate, the
authority vested in the Secretary of HHS
by section 212(1) of the Department of
Defense and Labor, Health and Human
Services, and Education Appropriations
Act, 2019 and Continuing
Appropriations Act, 2019 (FY 19 HHS
Appropriations Act) Public Law 115–
245, division B, title II, or substantially
similar authorities vested in the
Secretary in the future by Congress, in
order to carry out international health
activities.
Section 212(1) of the FY19 HHS
Appropriations Act permits the
Secretary of HHS to exercise authority
equivalent to that available to the
Secretary of State under 22 U.S.C
2669(c) to award personal services
contracts for work performed in foreign
countries. The authority delegated
herein includes the authority to
determine the necessity of negotiating,
executing, and performing such
contracts without regard to statutory
provisions as related to the negotiation,
making, and performance of contracts
and performance of work in the United
States.
The authority under section 212(1) is
immediately revoked in the event that
any subsequent fiscal year HHS
appropriations act does not contain the
provision currently in section 212(1) or
substantially similar authority.
The Chief Operating Officer, CDC,
shall consult with the Secretary of State
and relevant Chief of Mission to ensure
that this authority is exercised in a
manner consistent with section 207 of
the Foreign Service Act of 1980 and
other applicable statutes administered
by the Department of State.
This delegation supersedes the
delegation of similar name, approved by
the Director, CDC, on March 17, 2020.
This delegation became effective on
January 31, 2022. The Director, CDC,
affirms and ratifies any actions taken
that involve the exercise of the authority
delegated herein prior to the effective
date of this delegation.
Sherri A. Berger,
Chief of Staff, Centers for Disease Control
and Prevention.
[FR Doc. 2022–02380 Filed 2–3–22; 8:45 am]
[FR Doc. 2022–02328 Filed 2–3–22; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
E:\FR\FM\04FEN1.SGM
04FEN1
]]>Agencies
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6550-6551]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02407]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
the Sierra Leone Ministry of Health and Sanitation
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $450,000 for Year 1 of funding to the Sierra
Leone (SL) Ministry of Health and Sanitation. The award will build
laboratory and Strategic Information (SI) capacity to improve the
provision of HIV testing, treatment, and retention in line with HIV
epidemic control and 95-95-95(95% of HIV-positive individuals knowing
their status, 95% of those receiving ART [Antiretroviral therapy], and
95% of those achieving viral suppression) targets. Funding amounts for
years 2-5 will be set at continuation.
DATES: The period for this award will be September 30, 2022 through
September 29, 2027.
FOR FURTHER INFORMATION CONTACT: Trong Ao, Center for Global Health,
Centers for Disease Control and Prevention, CDC Ghana Office, U.S.
Embassy, 24 Fourth Circular Road Cantonments, Accra, Ghana, Telephone:
800-232-6348, Email: [email protected].
[[Page 6551]]
SUPPLEMENTARY INFORMATION: The single-source award will support the
National AIDS Control Program of Sierra Leone (SL) in the Ministry of
Health and Sanitation to implement HIV strategic information and
laboratory strengthening activities in SL. This award will build and
strengthen laboratories that are equipped with the appropriate
diagnostic technologies, trained and skilled staff, and systems that
have the capability to provide efficient services. It will also
strengthen SI systems, data quality assurance and capacity of staff
responsible for managing facility-based survey and surveillance data
operating at national and subnational levels. As the mandated
institution to provide HIV treatment clinical services and guidelines
in SL, the Sierra Leone Ministry of Health and Sanitation is in a
unique position to conduct this work. The National HIV/AIDS control
program is one of the specialized programs within the Ministry of
Health.
Summary of the Award
Recipient: Sierra Leone Ministry of Health and Sanitation.
Purpose of the Award: The purpose of this award is to build
laboratory and SI capacity to improve the provision of HIV testing,
treatment, and retention in line with HIV epidemic control and 95-95-95
targets. The award will build and strengthen laboratories that are
equipped with the appropriate diagnostic technologies, trained and
skilled staff, and systems that have the capability to provide
efficient services.
Amount of Award: The approximate year 1 funding amount will be
$450,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the
availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003).
Period of Performance: September 30, 2022 through September 29,
2027.
Dated: February 1, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2022-02407 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P
